Pharmaceutical industry in India
- 1. Presented By :- Guided by:- Ms. Rupali Gole Mr. Ravi Sahu Sir Ms. Neha Kadu Mr. Sarvesh Rathi Sir Ms. Shireen Bobade 1
- 2. 2
- 3. CONTENTS:- Introduction Of Pharmaceutical Industry Indian Pharmaceutical Evolution Significance of Pharma Industry Function of Pharma Companies Why Pharma Industry Grow Major Pharmaceutical Companies in India Government Initiatives and Investments Challenge and Future Growth Opportunity 3
- 4. IPI is worlds 3rd largest in terms of volume and 14th terms of value. Top 5th pharma market globally. Domestic pharma market Rs.6370 corer (US.$1.03 bn) IPI is estimated to be worth US.$4.5 bn. 20000 registered units,250 large units and 8000 small scale units. Source ;- www.cci.in 4
- 5. Phase I 1970 :- 1) Market share domination by foreign companies. 2) Relative absence of organized India companies. Phase II 1980 Government Control :- 1) Indian patent act – 1970 2) Drug price capped 3) Local companies begin to make an impact Source;- www.carerating.co 5
- 6. Phase III 1990 Development Phase :- 1) Process development 2) Production infrastructure creation 3) Export initiatives Phase IV 2000 Growth Phase :- 1)Rapid expansion of domestic market 2) International Market development 3) Research Orientation Phase V 2010 Innovation and Research 1)New IP Law 2)Discovery Research 3)Convergence Source;- www.camrerating.co 6
- 7. Competent workforce Cost-effective chemical synthesis Legal & Financial Framework Information & Technology Globalization Source;- Wikipedia 7
- 8. FOUR MAJOR FUNCTIONS: 1. Research and Development 2. Regulators 3. Production 4. Quality 5. Marketing 8
- 9. Increasing a medical facilities Increasing chronic diseases Increasing in health insurance coverage Good Manufacturing Practices (GMP) (WHO GMP Protocols) Good Clinical Practices (GCP) Good laboratory Practices (GLP) Source;- www.cdsco.nic.in 9
- 10. 196 23 14 14 14 13 12 11 7 0 50 100 150 200 250 Chart Title Column1 Source;-Mckinsey India and company 10
- 11. Company Name Sales in INR billion Cipla 69.77 Ranbaxy Lab 76.86 Dr. Reddy’s Labs 66.86 Sun Pharma 40.15 Lupin Ltd. 53.64 Aurobindo Pharma 42.84 Jubilant Life 26.41 Cadila Health 31.52 Ipca Labs 23.52 Wockhardt 26.50 Source;- www.cci.in 11
- 12. Established a various Organization Tax incentives & grants for Biotech start up and firms. The Ministry of Health & Family Welfare examines pharmaceutical issues. It established the Department of Biotechnology in 1986 under the Ministry of Science and Technology. Source;-www.cdsco.nic.in). 12
- 13. Indian Pharma industry would have to contend several challenges particularly I. Effects of new product patent II. Drugs price control III. Regulatory reforms IV. Infrastructure development V. Quality management VI. Conformance to global standards 13
- 14. 14
- 15. 15
- 16. 16